NeuroBo Pharmaceuticals (NRBO) Short Interest Ratio & Short Volume $0.73 -0.08 (-9.35%) As of 04/16/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NeuroBo Pharmaceuticals Short Interest DataNeuroBo Pharmaceuticals (NRBO) has a short interest of 34,300 shares, representing 1.14% of the float (the number of shares available for trading by the public). This marks a 78.65% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 47,830 shares to cover all short positions.Current Short Interest34,300 sharesPrevious Short Interest19,200 sharesChange Vs. Previous Month+78.65%Dollar Volume Sold Short$76,146.00Short Interest Ratio0.8 Days to CoverLast Record DateNovember 15, 2024Outstanding Shares8,616,000 sharesFloat Size3,000,000 sharesShort Percent of Float1.14%Today's Trading Volume1,293,720 sharesAverage Trading Volume47,830 sharesToday's Volume Vs. Average2,705% Short Selling NeuroBo Pharmaceuticals? Sign up to receive the latest short interest report for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNRBO Short Interest Over TimeNRBO Days to Cover Over TimeNRBO Percentage of Float Shorted Over Time NeuroBo Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/202434,300 shares $76,146.00 +78.7%1.1%0.8 $2.22 10/31/202419,200 shares $49,344.00 -20.3%0.6%0.5 $2.57 10/15/202424,100 shares $60,973.00 -25.6%0.8%0.6 $2.53 9/30/202432,400 shares $102,708.00 -2.7%1.1%0.8 $3.17 9/15/202433,300 shares $120,213.00 +18.5%1.1%0.6 $3.61 8/31/202428,100 shares $103,689.00 -35.6%1.0%0.5 $3.69 8/15/202443,600 shares $170,476.00 +32.9%1.6%0.9 $3.91 7/31/202432,800 shares $133,496.00 -37.8%10.1%0.5 $4.07 7/15/202452,700 shares $263,500.00 -43.1%16.2%0.9 $5.00 6/30/202492,600 shares $448,184.00 +58.3%41.3%1.6 $4.84 Get the Latest News and Ratings for NRBO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 6/15/202458,500 shares $222,885.00 -6.9%2.9%1.3 $3.81 5/31/202462,800 shares $239,268.00 +74.9%3.1%1.4 $3.81 5/15/202435,900 shares $152,216.00 -11.6%1.8%0.3 $4.24 4/30/202440,600 shares $133,980.00 -21.8%2.1%0.3 $3.30 4/15/202451,900 shares $183,207.00 -16.2%2.6%0 $3.53 3/31/202461,900 shares $253,171.00 -9.5%1.9%0 $4.09 3/15/202468,400 shares $314,640.00 +67.2%2.2%0.1 $4.60 2/29/202440,900 shares $236,811.00 -68.9%1.3%0 $5.79 2/15/2024131,700 shares $636,111.00 +395.1%4.1%0.1 $4.83 1/31/202426,600 shares $86,982.00 +39.3%0.8%0 $3.27 1/15/202419,100 shares $64,558.00 +180.9%0.4%0.6 $3.38 12/31/20236,800 shares $25,136.88 +15.3%0.2%0.2 $3.70 12/15/20235,900 shares $23,590.56 -90.1%0.2%0.5 $4.00 11/30/202359,600 shares $26,700.80 -31.8%N/A1 $0.45 11/15/202387,400 shares $37,599.48 -2.7%N/A1.3 $0.43 10/31/202389,800 shares $37,805.80 -29.5%N/A0.8 $0.42 10/15/2023127,400 shares $60,757.06 +4.3%N/A0.8 $0.48 9/30/2023122,200 shares $58,167.20 +11.1%N/A0.5 $0.48 9/15/2023110,000 shares $59,367.00 -20.1%N/A0.3 $0.54 8/31/2023137,700 shares $61,290.27 -48.0%0.8%0.4 $0.45 8/15/2023265,000 shares $163,770.00 +217.4%1.5%0.7 $0.62 7/31/202383,500 shares $42,835.50 -57.9%0.7%0.2 $0.51 7/15/2023198,500 shares $86,645.25 -67.5%1.5%0.5 $0.44 6/30/2023611,400 shares $267,242.94 +224.5%4.6%1.3 $0.44 6/15/2023188,400 shares $93,069.60 -20.6%1.4%0.5 $0.49 5/31/2023237,400 shares $132,944.00 -9.0%1.8%0.6 $0.56 5/15/2023261,000 shares $154,746.90 +15.6%2.0%0.5 $0.59 4/30/2023225,800 shares $144,512.00 +33.9%1.7%0.4 $0.64 4/15/2023168,600 shares $123,078.00 -26.5%2.3%0.2 $0.73 3/31/2023229,300 shares $162,871.79 -13.3%3.1%0.3 $0.71Can you still profit from AI this year? (Read this ASAP) (Ad)AI isn’t dead — it’s just getting started. Weiss Ratings — ranked #1 by both the SEC and the Wall Street Journal — just issued 3 new “Buy” signals on under-the-radar AI stocks. See the names and ticker symbols now (for free).Missed Nvidia? These 3 Weiss picks could lead the next AI rally 3/15/2023264,500 shares $177,320.80 +28.1%4.2%0.2 $0.67 2/28/2023206,500 shares $132,160.00 -40.9%3.3%0.1 $0.64 2/15/2023349,400 shares $251,218.60 -46.1%5.6%0.1 $0.72 1/31/2023648,700 shares $512,473.00 +359.7%10.3%0.2 $0.79 1/15/2023141,100 shares $108,618.78 -85.3%2.2%0 $0.77 12/30/2022958,400 shares $687,652.00 -14.4%15.3%0.3 $0.72 12/15/20221,120,000 shares $1.69 million +29.4%N/A0.3 $1.51 11/30/2022865,400 shares $1.25 million -47.6%N/A0.3 $1.45 11/15/20221,650,000 shares $2.34 million +837.0%45.1%0.6 $1.42 10/31/2022176,100 shares $1.35 million +257.2%9.2%0.1 $7.68 10/15/202249,300 shares $628,575.00 -46.8%9.6%0.1 $12.75 9/30/202292,600 shares $1.27 million -12.3%17.9%0.2 $13.69 9/15/2022105,600 shares $2.62 million -34.5%24.7%0.2 $24.82 8/31/2022161,300 shares $51,422.44 -7.5%1.3%0.1 $0.32 8/15/2022174,400 shares $71,172.64 -5.4%1.4%2 $0.41 7/31/2022184,300 shares $77,664.02 -17.7%1.4%1.9 $0.42 7/15/2022223,900 shares $125,406.39 +2.8%1.9%1.9 $0.56 6/30/2022217,900 shares $104,548.42 +17.2%1.9%1.7 $0.48 6/15/2022186,000 shares $74,772.00 -7.4%1.6%1.4 $0.40 5/31/2022200,900 shares $89,199.60 -15.8%1.7%1 $0.44 5/15/2022238,500 shares $121,444.20 -13.1%2.1%1.3 $0.51 4/30/2022274,400 shares $176,439.20 -8.8%2.4%1.5 $0.64 4/15/2022301,000 shares $261,659.30 -7.9%2.6%1.6 $0.87 3/31/2022326,900 shares $294,896.49 +31.6%2.9%1.6 $0.90 3/15/2022248,500 shares $191,842.00 +9.2%2.2%0.4 $0.77 2/28/2022227,500 shares $179,725.00 -6.0%2.0%0.4 $0.79 2/15/2022242,100 shares $225,153.00 -35.7%2.1%0.4 $0.93 1/31/2022376,500 shares $391,560.00 -9.5%3.3%0.6 $1.04 1/15/2022416,000 shares $544,960.00 +423.9%3.6%0.6 $1.31 12/31/202179,400 shares $96,868.00 +44.9%0.7%0.1 $1.22 12/15/202154,800 shares $76,720.00 -34.7%0.5%0.1 $1.40 11/30/202183,900 shares $135,079.00 +75.5%0.7%0.2 $1.61 11/15/202147,800 shares $87,474.00 -53.9%0.4%0.1 $1.83 10/29/2021103,600 shares $183,372.00 -77.5%1.1%0.2 $1.77 10/15/2021460,600 shares $875,140.00 +340.8%4.9%0.8 $1.90 9/30/2021104,500 shares $388,740.00 -11.1%1.1%0 $3.72 9/15/2021117,600 shares $453,936.00 -18.8%1.5%0.1 $3.86 8/31/2021144,800 shares $599,472.00 -40.8%1.8%0.1 $4.14 8/13/2021244,500 shares $865,530.00 -43.0%3.1%0.1 $3.54 7/30/2021429,200 shares $1.41 million +122.4%5.4%0.2 $3.29 7/15/2021193,000 shares $528,820.00 -14.8%2.5%0.1 $2.74 6/30/2021226,400 shares $753,912.00 -52.8%2.9%0.9 $3.33 6/15/2021479,300 shares $1.60 million +18.8%6.2%1.9 $3.34 5/28/2021403,400 shares $1.14 million +7.1%5.3%3.3 $2.82 5/14/2021376,600 shares $1.04 million +4.8%4.9%2.6 $2.77 4/30/2021359,300 shares $1.28 million +4.3%4.7%1.7 $3.56 4/15/2021344,500 shares $1.30 million +8.4%4.5%0.9 $3.76 3/31/2021317,800 shares $1.35 million +143.3%4.2%0.8 $4.26 3/15/2021130,600 shares $578,558.00 -6.6%1.7%0.3 $4.43 2/26/2021139,800 shares $648,672.00 -42.1%1.6%0.4 $4.64Can you still profit from AI this year? (Read this ASAP) (Ad)AI isn’t dead — it’s just getting started. Weiss Ratings — ranked #1 by both the SEC and the Wall Street Journal — just issued 3 new “Buy” signals on under-the-radar AI stocks. See the names and ticker symbols now (for free).Missed Nvidia? These 3 Weiss picks could lead the next AI rally 2/12/2021241,500 shares $1.34 million -73.3%2.7%0.7 $5.53 1/29/2021902,900 shares $5.16 million +545.4%14.3%2.9 $5.72 1/15/2021139,900 shares $864,582.00 +2.6%2.2%1.3 $6.18 12/31/2020136,400 shares $754,292.00 +11.7%2.9%2.2 $5.53 12/15/2020122,100 shares $667,887.00 -3.3%2.2%6.9 $5.47 11/30/2020126,300 shares $684,546.00 -0.8%2.3%8 $5.42 11/15/2020127,300 shares $669,598.00 +1.9%2.3%7.4 $5.26 10/30/2020124,900 shares $666,966.00 -5.5%2.2%6.8 $5.34 10/15/2020132,200 shares $831,538.00 -1.9%2.4%4.6 $6.29 9/30/2020134,800 shares $757,576.00 +7.8%2.4%3.2 $5.62 9/15/2020125,100 shares $783,126.00 -17.0%2.2%1.9 $6.26 8/31/2020150,700 shares $916,256.00 -11.4%2.7%2.1 $6.08 8/14/2020170,100 shares $1.12 million -16.0%3.1%2.3 $6.57 7/31/2020202,500 shares $1.30 million -34.7%3.7%2.9 $6.41 7/15/2020309,900 shares $2.38 million +54.3%5.6%5 $7.69 6/30/2020200,800 shares $1.67 million +184.0%3.6%3.6 $8.31 6/15/202070,700 shares $671,650.00 +12.0%1.3%2.3 $9.50 5/29/202063,100 shares $831,027.00 +3.6%1.1%2.7 $13.17 5/15/202060,900 shares $801,444.00 +407.5%1.1%2.7 $13.16 4/30/202012,000 shares $170,520.00 +100.0%0.2%0.4 $14.21 NRBO Short Interest - Frequently Asked Questions What is NeuroBo Pharmaceuticals' current short interest? Short interest is the volume of NeuroBo Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 15th, investors have sold 34,300 shares of NRBO short. 1.14% of NeuroBo Pharmaceuticals' shares are currently sold short. Learn More on NeuroBo Pharmaceuticals' current short interest. What is a good short interest ratio for NeuroBo Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NRBO shares currently have a short interest ratio of 1.0. Learn More on NeuroBo Pharmaceuticals's short interest ratio. Which institutional investors are shorting NeuroBo Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of NeuroBo Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for NeuroBo Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.14% of NeuroBo Pharmaceuticals' floating shares are currently sold short. Is NeuroBo Pharmaceuticals' short interest increasing or decreasing? NeuroBo Pharmaceuticals saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 34,300 shares, an increase of 78.6% from the previous total of 19,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NeuroBo Pharmaceuticals' float size? NeuroBo Pharmaceuticals currently has issued a total of 8,616,000 shares. Some of NeuroBo Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NeuroBo Pharmaceuticals currently has a public float of 3,000,000 shares. How does NeuroBo Pharmaceuticals' short interest compare to its competitors? 1.14% of NeuroBo Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "banking" compare to NeuroBo Pharmaceuticals: Digihost Technology Inc. (1.20%), CFSB Bancorp, Inc. (0.31%), Texas Community Bancshares, Inc. (0.08%), Stronghold Digital Mining, Inc. (5.15%), Catalyst Bancorp, Inc. (0.17%), MDB Capital Holdings, LLC (0.03%), OptimumBank Holdings, Inc. (0.25%), Home Federal Bancorp, Inc. of Louisiana (0.24%), Usio, Inc. (0.46%), Binah Capital Group, Inc. (1.62%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks. What does it mean to sell short NeuroBo Pharmaceuticals stock? Short selling NRBO is an investing strategy that aims to generate trading profit from NeuroBo Pharmaceuticals as its price is falling. NRBO shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NeuroBo Pharmaceuticals? A short squeeze for NeuroBo Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NRBO, which in turn drives the price of the stock up even further. How often is NeuroBo Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NRBO, twice per month. The most recent reporting period available is November, 15 2024. More Short Interest Resources from MarketBeat Related Companies DGHI Short Interest Data CFSB Short Interest Data TCBS Short Interest Data SDIG Short Interest Data CLST Short Interest Data MDBH Short Interest Data OPHC Short Interest Data HFBL Short Interest Data USIO Short Interest Data BCG Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NRBO) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroBo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NRBO Stock Free NRBO Stock Alerts